MedTrace Logo

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

NCT04920474 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 99999999

Last updated 2023-05-03

No results posted yet for this study

Summary

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellular therapy.

Representatives of participating centers and investigators or research groups may request access to research samples contained in the Research Sample Repository for the purpose of conducting research including:

* investigating molecular explanations for histocompatibility or clinical outcomes through analysis of genomic, epigenetic, or other biomolecular data
* evaluating the factors that affect transplant or cellular therapy outcome
* studying the distribution of HLA tissue types in different populations
* studying the success of transplantation, cellular therapies or supportive care in the management of marrow toxic injuries
* performing de-linked (anonymous) research

Conditions

  • Autologous Stem Cell Transplantation
  • Allogeneic Stem Cell Transplantation
  • Cellular Therapy
  • Marrow Toxic Injury

Sponsors & Collaborators

Principal Investigators

  • Stephen Spellman · NMDP Be The Match/CIBMTR

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-07-31
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920474 on ClinicalTrials.gov